Efficacy of Dupilumab in Treating Atopic Dermatitis With Recurrent Eczema Herpeticum in a Patient With DOCK8-Deficiency Hyper-IgE Syndrome: A Case Report.
dock8-deficiency
dupilumab
eczema
herpes
hyper-ige syndrome
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
21
07
2023
medline:
13
9
2023
pubmed:
13
9
2023
entrez:
13
9
2023
Statut:
epublish
Résumé
Dupilumab, a monoclonal antibody targeting interleukin 4 and interleukin 13, was used to successfully induce remission of chronic, disseminated eczema herpeticum in a six-year-old girl who has DOCK8-deficiency hyper-IgE syndrome. The patient was started on 200 mg of dupilumab administered once every four weeks. The patient had achieved complete resolution of all active herpetic lesions by the time her third dose was due. During the course of three months, she had not developed any new lesions, and significant improvement of the patient's skin, scalp, hair restoration, and nails was appreciated.
Identifiants
pubmed: 37701007
doi: 10.7759/cureus.43360
pmc: PMC10494277
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e43360Informations de copyright
Copyright © 2023, Johar et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Clin Immunol. 2017 Aug;181:75-82
pubmed: 28625885
Ann N Y Acad Sci. 2011 Dec;1246:26-33
pubmed: 22236427
Eur J Immunol. 2011 Dec;41(12):3423-35
pubmed: 21969276
N Engl J Med. 2009 Nov 19;361(21):2046-55
pubmed: 19776401
J Allergy Clin Immunol. 2015 Aug;136(2):402-12
pubmed: 25724123
BMC Neurol. 2021 Jul 23;21(1):288
pubmed: 34301197
J Allergy Clin Immunol. 2014 Jun;133(6):1753-5.e3
pubmed: 24767873
Orphanet J Rare Dis. 2011 Nov 15;6:76
pubmed: 22085750
J Clin Immunol. 2012 Aug;32(4):698-708
pubmed: 22476911
Annu Rev Immunol. 1997;15:297-322
pubmed: 9143690
Clin Immunol. 2012 Jun;143(3):266-72
pubmed: 22534316
Curr Allergy Asthma Rep. 2018 Aug 15;18(10):51
pubmed: 30112673
J Allergy Clin Immunol. 2009 Dec;124(6):1289-302.e4
pubmed: 20004785
P T. 2018 Sep;43(9):532-535
pubmed: 30186024
Arch Dermatol. 2012 Jan;148(1):79-84
pubmed: 21931011
Acta Derm Venereol. 2016 Nov 2;96(7):991-992
pubmed: 26573532
J Clin Immunol. 2015 Feb;35(2):189-98
pubmed: 25627830